C2C Wealth Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
LMFP
AAMU
CRM
SP
ORIO
CNB
C2C Wealth Management's MRK Position: Q2 2026 in Review
C2C Wealth Management reduced its Merck (MRK) stake by 8% in Q2 2026, selling an estimated $20.1K and leaving 1,981 shares worth $255K. The position accounts for 0.2% of the portfolio, ranked #77.
C2C Wealth Management first reported a position in MRK in Q4 2021 and has held it in 17 quarters since. The position peaked at $1.79M in Q1 2023. 711 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- C2C Wealth Management held 1,981 shares of Merck worth $255K as of Q2 2026.
- C2C Wealth Management sold 172 Merck shares in Q2 2026, an estimated $20.1K.
- Merck made up 0.2% of C2C Wealth Management's portfolio in Q2 2026, its #77 holding.
- C2C Wealth Management first reported a position in Merck in Q4 2021 and has held it in 17 quarters since.
- C2C Wealth Management's Merck position peaked at $1.79M in Q1 2023.
- 711 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on C2C Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.